Evaluation of Prooxidant–Antioxidant Balance in Chronic Heroin Users in a Single Assay: An Identification Criterion For Antioxidant Supplementation

REFERENCES

• Pan J, Zhang Q, Zhang Y, Ouyang Z, Zheng Q, Zheng R. Oxidative stress in heroin administered mice and natural antioxidants protection. Life Sci 2005; 77(2):183–193.
   PubMed Web of Science ®Google Scholar
• Xu B, Wang Z, Li G, Li B, Lin H, Zheng R, Zheng Q. Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin Pharmacol Toxicol 2006; 99(2):153–161.
   PubMed Web of Science ®Google Scholar
• Kovatsi L, Njau S, Nikolaou K, Tsolakidou A, Karamouzis I, Thisiadou K. Isoprostane as a marker of oxidative stress in chronic heroin users. Correlation with duration of heroin use or concomitant hepatitis C infection. Am J Drug Alcohol Abuse 2010; 36(1):13–17.
   PubMed Web of Science ®Google Scholar
• Pereska Z, Dejanova B, Bozinovska C, Petkovska L. Prooxidative/antioxidative homeostasis in heroin addiction and detoxification. Bratisl Lek Listy 2007; 108(9):393–398.
   PubMed Web of Science ®Google Scholar
• Zhou JF, Yan XF, Ruan ZR, Peng FY, Cai D, Yuan H. Heroin abuse and nitric oxide, oxidation, peroxidation, lipoperoxidation. Biomed Environ Sci 2000; 13:131–9.
   PubMed Web of Science ®Google Scholar
• Zhou J, Si P, Ruan Z, Ma S, Yan X, Sun L, Peng F, Yuan H, Cai D, Ding D, Xu S. Primary studies on heroin abuse and injury induced by oxidation and lipoperoxidation. Chin Med J (Engl) 2001; 114:297–302.
   PubMed Web of Science ®Google Scholar
• Evangelou A, Kalfakakou V, Georgakas P, Koutras V, Vezyraki P, Iliopoulou L, Vadalouka A. Ascorbic acid (vitamin C) effects on withdrawal syndrome of heroin abusers. In Vivo 2000; 14(2):363–366.
   PubMed Web of Science ®Google Scholar
• Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007; 40(3-4):248–254.
   PubMed Web of Science ®Google Scholar
• Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, Kazemi-Bajestani SM, Paletas K, Pegiou T, Koliakos G. Prooxidant–antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008; 41:375–380.
   PubMed Web of Science ®Google Scholar
• Muriel P. Role of free radicals in liver diseases. Hepatol Int 2009 Nov 26. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association, 1994.
   Google Scholar
• McLellan A, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O'Brien CP. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 1985; 173:412–423.
   PubMed Web of Science ®Google Scholar
• Qiusheng Z, Yuntao Z, Rongliang Z, Dean G, Changling L. Effects of verbascoside and luteolin on oxidative damage in brain of heroin treated mice. Pharmazie 2005; 60(7):539–543.
   PubMed Web of Science ®Google Scholar
• Arana C, Cutando A, Ferrera MJ, Gómez-Moreno G, Worf CV, Bolaños MJ, Escames G, Acuña-Castroviejo D. Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med 2006; 35(9):554–559.
   PubMed Web of Science ®Google Scholar
• Goudas LC, Langlade A, Serrie A, Matson W, Milbury P, Thurel C, Sandouk P, Carr DB. Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain. Anesth Analg 1999; 89(5):1209–1215.
   PubMed Web of Science ®Google Scholar
• Zhang YT, Zheng QS, Pan J, Zheng RL. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin Pharmacol Toxicol 2004; 95(2):53–58.
   PubMed Web of Science ®Google Scholar
• Patel J, Manjappa N, Bhat R, Mehrotra P, Bhaskaran M, Singhal PC. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am J Physiol Renal Physiol 2003; 285(5):861–869.
   Web of Science ®Google Scholar
• Sharp BM, Keane WF, Suh HJ, Gekker G, Tsukayama D, Peterson PK. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985; 117:793–795.
   PubMed Web of Science ®Google Scholar
• Singhal PC, Pamarthi M, Shah R, Chandra D, Gibbons N. Morphine stimulates superoxide formation by glomerular mesangial cells. Inflammation 1994; 18(3):293–299.
   PubMed Web of Science ®Google Scholar
• Di Bello MG, Masini E, Ioannides C, Fomusi Ndisang J, Raspanti S, Bani Sacchi T, Mannaioni PF. Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res 1998; 47(3):122–130.
   PubMed Web of Science ®Google Scholar
• Tretjak Z, Knight J, Wilkins J, Setoda D, Voorhees R. Lipoperoxides in serum of substance users and controls. Ann Clin Lab Sci 1992; 22:214–220.
   PubMed Web of Science ®Google Scholar
• Jain SK, Pemberton PW, Smith A, McMahon RFT, Burrows PC, Aboutwerat A, Warnes TW. Oxidative stress in chronic hepatitis C: Not just a feature of late stage disease. J Hepatol 2002; 36:805–811.
   PubMed Web of Science ®Google Scholar
• Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, Ikeda H, Hanano S, Suehiro M, Togawa K, Yamada G. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 2004; 6:19–24.
   PubMed Web of Science ®Google Scholar
• Choi J, Ou JH. Mechanisms of liver injury: III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006; 290:G847–G851.
   PubMed Web of Science ®Google Scholar
• Tang AM, Forrester JE, Spiegelman D, Flanigan T, Dobs A, Skinner S, Wanke C. Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities. Am J Drug Alcohol Abuse 2010; 36(1):78–86.
   PubMed Web of Science ®Google Scholar
• Santolaria-Fernández FJ, Gómez-Sirvent JL, González-Reimers CE, Batista-López JN, Jorge-Hernández JA, Rodríguez-Moreno F, Martínez-Riera A, Hernández-García MT. Nutritional assessment of drug addicts. Drug Alcohol Depend 1995; 38(1):11–18.
   PubMed Web of Science ®Google Scholar
• Junhua L, Zhenhua W, Bao J, Qiusheng Z. Heroin-Induced Hepatotoxicity: Involved Oxidative Stress. The 2nd International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2008, pp. 1112–1118.
   Google Scholar
• Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin J Am Soc Nephrol 2006; 1(4):655–667.
   PubMed Web of Science ®Google Scholar
• Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, Gibbons N. Morphine enhances macrophage apoptosis. J Immunol 1998; 160(4):1886–1893.
   PubMed Web of Science ®Google Scholar
• Singhal PC, Kapasi AA, Franki N, Reddy K. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology 2000; 100(1):57–62.
   PubMed Web of Science ®Google Scholar
• Bhaskaran M, Reddy K, Sharma S, Singh J, Radhakrishnan N, Kapasi A, Singhal PC. Morphine-induced degradation of the host defense barrier: role of macrophage injury. J Infect Dis 2001; 184(12):1524–1531.
   PubMed Web of Science ®Google Scholar
• Patel K, Bhaskaran M, Dani D, Reddy K, Singhal PC. Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages. J Infect Dis 2003; 187(1):47–54.
   PubMed Web of Science ®Google Scholar
• Bhat RS, Bhaskaran M, Mongia A, Hitosugi N, Singhal PC. Morphine-induced macrophage apoptosis: Oxidative stress and strategies for modulation. J Leukoc Biol 2004; 75(6):1131–1138.
   PubMed Web of Science ®Google Scholar
• Batista A, Macedo T, Tavares P, Ribeiro CF, Relvas J, Gomes P, Ramalheira C, Botto I, Vale L, Ferreira L, Guete O, Ruiz G. Nitric oxide production and nitric oxide synthase expression in platelets from heroin abusers before and after ultrarapid detoxification. Ann N Y Acad Sci 2002; 965:479–486.
   PubMed Web of Science ®Google Scholar
• Gutowicz M, Sadurska B, Chołojczyk M, Pokorska-Lis M, Siwińska-Ziółkowska A, Barańczyk-Kuźma A. Antioxidant status in different regions of heroin addicts' brain. Environ Toxicol Pharmacol 2006; 21(1):80–85.
   PubMed Web of Science ®Google Scholar
• Violi F, Cangemi R. Antioxidants and cardiovascular disease. Curr Opin Investig Drugs 2005; 6:895–900.
   PubMedGoogle Scholar
• Violi F, Cangemi R, Sabatino G, Pignatelli P. Vitamin E for the treatment of cardiovascular disease: is there a future? Ann N Y Acad Sci USA 2004; 1031:292–304.
   PubMed Web of Science ®Google Scholar